The BioHub - by Avetix

From BIO Boston: Adam Mendelsohn, CEO of Vivani Medical In this episode, I sit down with Adam Mendelsohn — bioengineer turned biotech CEO — and the co-founder of Vivani Medical. What started in a university basement has grown into a publicly listed company tackling one of the biggest challenges in healthcare: medication adherence. We talk about: — Building a biotech from scratch, and staying alive...

From BIO Boston: Steve Butts, CEO of Arrivo BioVentures In this episode, I sit down with Steve Butts — a five-time biotech founder and the CEO of Arrivo BioVentures. Steve has built and exited multiple companies, and now he's applying everything he’s learned to build Arrivo with precision: lean, capital-efficient, and structured for smart growth. We talk about: — How to build programs that big...

Lisa DiPaolo is the Executive Vice President and Chief Human Resources Officer at Karyopharm Therapeutics, where she brings over two decades of HR leadership in the pharmaceutical and biotech industries. Since joining Karyopharm in September 2022, she has led the company’s People & Culture strategy through a critical period of growth and transformation. Before this, Lisa served as SVP of HR at...

Dr. Aaron Royston, M.D., M.B.A., is a Managing Partner at venBio, a life sciences venture capital firm, where he brings over 15 years of experience in biotechnology investing, company formation, and clinical research. His leadership has contributed to the launch and growth of several successful biotech companies, including Apellis Pharmaceuticals, Ventyx Biosciences, Akero Therapeutics, Harmony Bi...

Dr. Harith Rajagopalan is the Co-founder and CEO of Fractyl Health, a company he launched while serving as an Entrepreneur-in-Residence at General Catalyst Partners. Before founding Fractyl, Dr. Rajagopalan was an academic cardiologist and physician-scientist. He earned his B.S. in Chemistry from Stanford University and obtained both M.D. and Ph. D. degrees from Johns Hopkins School of Medicine. A...

Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry. In this special follow-up episode, I’m rejoined by Marc de Garidel, CEO of Abivax, after our hugely popular conversation last year—recorded just after their record-breaking NASDAQ IPO. That episode gave us a look into Marc’s incredible career, the company’s bold vision, and how they were gea...

Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry. I’m joined by Lisa Deschamps, CEO of AviadoBio. After 25 years at Novartis, leading global launches in gene therapy, she’s now at the helm of AviadoBio—developing treatments for FTD and ALS. We talk career moves, mindset, culture, and what’s ahead. Enjoy and stay tuned.

We're honored to have Dr. Michael Kauffman, M.D., Ph. D., the Chief Executive Officer of Nereid Therapeutics, joining us. Dr. Kauffman brings over 25 years of experience in the life sciences industry, with a distinguished track record in oncology drug development. Currently, he leads Nereid Therapeutics, a company at the forefront of pioneering therapies targeting biomolecular condensates—a novel...

We were delighted to be joined by Julie Person on the BioHub podcast, an accomplished human resources and organizational leader with over 20 years of experience in the biopharmaceutical industry. She currently serves as Chief Administrative Officer at Third Harmonic Bio, where she leads company operations, including human resources, communications, and organizational strategy. Julie has a strong t...

Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry. I’m joined by Alexander Zehnder , CEO of CureVac — a company that’s been pioneering mRNA technology for 25 years. Alexander stepped into the CEO role in 2023 and has been leading CureVac through a critical transformation: securing a €1.45 billion partnership with GSK, executing a strategic p...

Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry. I’m joined by Dr. Claudia Zylberberg — a pioneering force in cell and gene therapy and the founder of Akron Biotech. Claudia has spent her career shaping the future of biologics manufacturing, building Akron into a key player in the CGT ecosystem, and championing the development of global st...

Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry. On this episode of The BioHub, I’m joined by Uwe Schoenbeck, Partner at Canaan and one of the most respected names in early-stage biotech. After more than a decade leading external science and innovation at Pfizer, Uwe made the jump to venture capital, joining Canaan in 2023. With a backgrou...

Our little spin off of our time at JPM! Big announcements and exclusives! Here we have David Happel, CEO of Sagimet Biosciences Listen to hear how they've been doing.

Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry. I’m joined by Gwen Acton, CEO of Vivo Group and an expert in leadership development for scientists, engineers, and biotech professionals. Gwen has had a fascinating career—she earned a PhD from MIT, was a faculty member at Harvard, ran operations at the Whitehead Institute during the Human G...

Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry. Today we're joined by David De Graaf, CEO of Co-Founder of Reverb TherapeuticsDavid has an incredible background, with positions at companies such as AstraZeneca, Pfizer, Apple Tree Partners & Boehringer Ingelheim as well being at the helm of multiple successful biotechs. In this epi...

Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry. I’m joined by Judy Chou, CEO of AltruBio—one of the mostexciting biotech companies out there, especially after closing the largest Series B in biotech over the last four years. Judy has an incredible background, having led global biotechat Bayer, held leadership roles at Pfizer, and served a...

Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry. I’m joined by Aoife Brennan, CEO of Climb Bio —a company at the cutting edge of pioneering new approaches to cell and gene therapy. Aoife is a seasoned biotech leader with a track record of driving innovation. Before joining Climb Bio, she was the CEO of Synlogic, where she led the company t...

Thank you for tuning into another episode of Bio Hub! Today, we have the privilege of hosting Shalabh Gupta, a seasoned leader in the biotech industry and the current Founder, Chairman & CEO of Unicycive Therapeutics. Shalabh's experience is vast, spanning over two decades in leadership roles across the biotech landscape. He has previously served as CEO of Globavir Biosciences and CEO, Fou...

Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry. I’m joined by Iain Kilty, CEO of Sitryx, a biotech pushing boundaries in immunology and inflammation. Iain’s journey is fascinating—after 22 years at Pfizer, leading global drug discovery efforts, he transitioned into biotech, taking on the CSO role at Sitryx before stepping up as CEO. Now,...

Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry. I’m joined by John Mumm, CEO of Deka Biosciences—a company breaking new ground in cytokine therapies for cancer and inflammatory diseases. John is a true veteran of biotech, with over 30 years of experience in immunotherapy research. He’s spent his career working to unlock the potential of I...

Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry. Melissa Sherman, CEO of MOBILion Systems—a true trailblazer shaking up separation science. Melissa was employee number one and has since raised $120M, built a world-class team, and launched Mobi, a technology that’s transforming how we analyze molecules. Think of it like upgrading from an ol...

Our little spin off of our time at JPM! Big announcements and exclusives! Here we have Stella Vnook, CEO of Likarda. Listen to hear how they've been doing.

Our little spin off of our time at JPM! Big announcements and exclusives! Here we have Patrick Alexandre, CEO of Crossject. Listen to hear how they've been doing.

Thank you for tuning into another episode of Bio Hub! Today, we have the privilege of hosting David Esposito, a seasoned leader in the biotech industry and the CEO of ONL Therapeutics. David's experience is vast, spanning over two decades in leadership roles across the biotech landscape. He has previously served as President and CEO of Armune Biosciences, VP Commercial Operations at Thermo Fis...

Our little spin off of our time at JPM! Big announcements and exclusives! Here we have Glen Gowers, CEO and co-Founder of Basecamp Research. Listen to hear how they've been doing.